About Future Care Capital
Future Care Capital is a Healthcare company based in London (United Kingdom) founded in 1945. Promotes innovation, evaluates impact, invests in health care solutions through partnerships. It operates on a Non-Profit and Impact Investment model in Healthcare and Technology sectors. Future Care Capital offers products and services including RYSE Fund and Extended Reality Paper. Its focus areas include Health and Social Care, Impact Investment, Systemic Transformation and Barrier Breaking Initiatives.
Company details
Future Care Capital is a UK charity dedicated to addressing barriers in health and care by fostering innovation management, impact evaluation, and impact investment. It convenes experts and stakeholders to develop solutions for systemic challenges, such as using extended reality in healthcare education. Based in London, it collaborates with innovators, providers, and investors to improve care outcomes and achieve long-term transformation through research, projects, and funds like the RYSE Fund.
- Headquarters London, United Kingdom
- SectorsHealthcareTechnology
- Website futurecarecapital.org.uk
- Social LinkedIn X Facebook
- Legal Name Future Care Capital
Products & Services of Future Care Capital
Future Care Capital offers a comprehensive portfolio of products and services, including RYSE Fund and Extended Reality Paper.
Supports investments to drive sustainable impact in health and care sectors.
Explores potential of extended reality for improving healthcare education access.
Web traffic of Future Care Capital
Websites that share an audience with Future Care Capital (futurecarecapital.org.uk).
Websites whose visitors overlap most with Future Care Capital. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| digitalhealth.net | 73% | 51.1K | #683,994 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Future Care Capital (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Future Care Capital
Future Care Capital was founded in 1945.
Future Care Capital is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Future Care Capital is a UK charity dedicated to addressing barriers in health and care by fostering innovation management, impact evaluation, and impact investment. It convenes experts and stakeholders to develop solutions for systemic challenges, such as using extended reality in healthcare education. Based in London, it collaborates with innovators, providers, and investors to improve care outcomes and achieve long-term transformation through research, projects, and funds like the RYSE Fund.
Future Care Capital offers RYSE Fund and Extended Reality Paper.
Future Care Capital operates through Future Care Capital.